ID MAX1_ARATH Reviewed; 522 AA. AC B9DFU2; O64853; Q940L3; DT 03-APR-2013, integrated into UniProtKB/Swiss-Prot. DT 03-MAY-2011, sequence version 1. DT 02-SEP-2026, entry version 94. DE RecName: Full=Cytochrome P450 711A1 {ECO:0000303|PubMed:15737939}; DE EC=1.14.-.- {ECO:0000269|PubMed:25425668}; DE AltName: Full=Protein MORE AXILLARY BRANCHES 1 {ECO:0000303|PubMed:15737939}; GN Name=CYP711A1 {ECO:0000303|PubMed:15737939}; GN Synonyms=MAX1 {ECO:0000303|PubMed:15737939}; GN OrderedLocusNames=At2g26170 {ECO:0000312|Araport:AT2G26170}; GN ORFNames=T19L18.2 {ECO:0000312|EMBL:AAM15001.1}, T1D16.2 GN {ECO:0000312|EMBL:AAC14532.2}; OS Arabidopsis thaliana (Mouse-ear cress). OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta; OC Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae; OC rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis. OX NCBI_TaxID=3702; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=cv. Columbia; RX PubMed=10617197; DOI=10.1038/45471; RA Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D., RA Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V., RA Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L., Moffat K.S., RA Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L., Tallon L.J., RA Gill J.E., Adams M.D., Carrera A.J., Creasy T.H., Goodman H.M., RA Somerville C.R., Copenhaver G.P., Preuss D., Nierman W.C., White O., RA Eisen J.A., Salzberg S.L., Fraser C.M., Venter J.C.; RT "Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana."; RL Nature 402:761-768(1999). RN [2] RP GENOME REANNOTATION. RC STRAIN=cv. Columbia; RX PubMed=27862469; DOI=10.1111/tpj.13415; RA Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S., RA Town C.D.; RT "Araport11: a complete reannotation of the Arabidopsis thaliana reference RT genome."; RL Plant J. 89:789-804(2017). RN [3] RP GENOME REANNOTATION. RC STRAIN=cv. Columbia; RG The Arabidopsis Information Resource (TAIR); RT "Community-consensus reference genome of Arabidopsis thaliana Col-0."; RL Submitted (FEB-2026) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=cv. Columbia; RX PubMed=14593172; DOI=10.1126/science.1088305; RA Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M., RA Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G., RA Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L., RA Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C., RA Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J., RA Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A., RA Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C., RA Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X., RA Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M., RA Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K., RA Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A., RA Ecker J.R.; RT "Empirical analysis of transcriptional activity in the Arabidopsis RT genome."; RL Science 302:842-846(2003). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=cv. Columbia; RX PubMed=19423640; DOI=10.1093/dnares/dsp009; RA Iida K., Fukami-Kobayashi K., Toyoda A., Sakaki Y., Kobayashi M., Seki M., RA Shinozaki K.; RT "Analysis of multiple occurrences of alternative splicing events in RT Arabidopsis thaliana using novel sequenced full-length cDNAs."; RL DNA Res. 16:155-164(2009). RN [6] RP FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE. RX PubMed=15737939; DOI=10.1016/j.devcel.2005.01.009; RA Booker J., Sieberer T., Wright W., Williamson L., Willett B., Stirnberg P., RA Turnbull C., Srinivasan M., Goddard P., Leyser O.; RT "MAX1 encodes a cytochrome P450 family member that acts downstream of RT MAX3/4 to produce a carotenoid-derived branch-inhibiting hormone."; RL Dev. Cell 8:443-449(2005). RN [7] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=16387852; DOI=10.1073/pnas.0509463102; RA Lazar G., Goodman H.M.; RT "MAX1, a regulator of the flavonoid pathway, controls vegetative axillary RT bud outgrowth in Arabidopsis."; RL Proc. Natl. Acad. Sci. U.S.A. 103:472-476(2006). RN [8] RP DISRUPTION PHENOTYPE. RX PubMed=20667910; DOI=10.1242/dev.051987; RA Crawford S., Shinohara N., Sieberer T., Williamson L., George G., RA Hepworth J., Mueller D., Domagalska M.A., Leyser O.; RT "Strigolactones enhance competition between shoot branches by dampening RT auxin transport."; RL Development 137:2905-2913(2010). RN [9] RP DISRUPTION PHENOTYPE. RX PubMed=21119045; DOI=10.1104/pp.110.164640; RA Kohlen W., Charnikhova T., Liu Q., Bours R., Domagalska M.A., Beguerie S., RA Verstappen F., Leyser O., Bouwmeester H., Ruyter-Spira C.; RT "Strigolactones are transported through the xylem and play a key role in RT shoot architectural response to phosphate deficiency in nonarbuscular RT mycorrhizal host Arabidopsis."; RL Plant Physiol. 155:974-987(2011). RN [10] RP DISRUPTION PHENOTYPE. RX PubMed=23204501; DOI=10.1093/mp/sss138; RA Fukui K., Ito S., Asami T.; RT "Selective mimics of strigolactone actions and their potential use for RT controlling damage caused by root parasitic weeds."; RL Mol. Plant 6:88-99(2013). RN [11] RP FUNCTION, SUBSTRATE SPECIFICITY, AND CATALYTIC ACTIVITY. RX PubMed=25425668; DOI=10.1073/pnas.1410801111; RA Abe S., Sado A., Tanaka K., Kisugi T., Asami K., Ota S., Kim H.I., RA Yoneyama K., Xie X., Ohnishi T., Seto Y., Yamaguchi S., Akiyama K., RA Yoneyama K., Nomura T.; RT "Carlactone is converted to carlactonoic acid by MAX1 in Arabidopsis and RT its methyl ester can directly interact with AtD14 in vitro."; RL Proc. Natl. Acad. Sci. U.S.A. 111:18084-18089(2014). RN [12] RP FUNCTION, AND DISRUPTION PHENOTYPE. RC STRAIN=cv. Columbia, cv. Landsberg erecta, and cv. Wassilewskija-4; RX PubMed=27194725; DOI=10.1073/pnas.1601729113; RA Brewer P.B., Yoneyama K., Filardo F., Meyers E., Scaffidi A., Frickey T., RA Akiyama K., Seto Y., Dun E.A., Cremer J.E., Kerr S.C., Waters M.T., RA Flematti G.R., Mason M.G., Weiller G., Yamaguchi S., Nomura T., Smith S.M., RA Yoneyama K., Beveridge C.A.; RT "LATERAL BRANCHING OXIDOREDUCTASE acts in the final stages of strigolactone RT biosynthesis in Arabidopsis."; RL Proc. Natl. Acad. Sci. U.S.A. 113:6301-6306(2016). RN [13] RP FUNCTION, AND DISRUPTION PHENOTYPE. RC STRAIN=cv. Columbia; RX PubMed=32399509; DOI=10.1002/pld3.219; RA Yoneyama K., Akiyama K., Brewer P.B., Mori N., Kawano-Kawada M., Haruta S., RA Nishiwaki H., Yamauchi S., Xie X., Umehara M., Beveridge C.A., Yoneyama K., RA Nomura T.; RT "Hydroxyl carlactone derivatives are predominant strigolactones in RT Arabidopsis."; RL Plant Direct 4:e00219-e00219(2020). CC -!- FUNCTION: Involved in the biosynthesis of strigolactone natural CC products, bioactive compounds promoting plant fitness and soil microbe CC interactions, but preventing shoot branching (PubMed:25425668, CC PubMed:32399509). Converts carlactone to carlactonoic acid by CC catalyzing consecutive oxidations at C-19 to convert the C-19 methyl CC group into carboxylic acid (PubMed:25425668). Prefers 11R-carlactone to CC 11S-carlactone as substrate (PubMed:25425668). Acts downstream of CC CCD7/MAX3 and CCD8/MAX4 in strigolactone signaling pathway and may be CC implicated in synthesis of carotenoid-derived branch regulators. Acts CC as a positive regulator of the flavonoid pathway in the late vegetative CC stage plant. Strigolactones are hormones that inhibit tillering and CC shoot branching through the MAX-dependent pathway, contribute to the CC regulation of shoot architectural response to phosphate-limiting CC conditions and function as rhizosphere signal that stimulates hyphal CC branching of arbuscular mycorrhizal fungi and trigger seed germination CC of root parasitic weeds (PubMed:15737939, PubMed:16387852). CC {ECO:0000269|PubMed:15737939, ECO:0000269|PubMed:16387852, CC ECO:0000269|PubMed:25425668, ECO:0000269|PubMed:32399509}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(11R)-carlactone + reduced [NADPH--hemoprotein reductase] + O2 CC = (11R)-19-hydroxycarlactone + oxidized [NADPH--hemoprotein CC reductase] + H2O + H(+); Xref=Rhea:RHEA:76083, Rhea:RHEA-COMP:11964, CC Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:194508, ChEBI:CHEBI:194510; CC Evidence={ECO:0000269|PubMed:25425668}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76084; CC Evidence={ECO:0000269|PubMed:25425668}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(11R)-19-hydroxycarlactone + reduced [NADPH--hemoprotein CC reductase] + O2 = (11R)-19-oxocarlactone + oxidized CC [NADPH--hemoprotein reductase] + 2 H2O + H(+); Xref=Rhea:RHEA:76091, CC Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:194510, ChEBI:CHEBI:194511; CC Evidence={ECO:0000269|PubMed:25425668}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76092; CC Evidence={ECO:0000269|PubMed:25425668}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(11R)-19-oxocarlactone + reduced [NADPH--hemoprotein CC reductase] + O2 = (11R)-carlactonoate + oxidized [NADPH--hemoprotein CC reductase] + H2O + 2 H(+); Xref=Rhea:RHEA:76095, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:194504, ChEBI:CHEBI:194511; CC Evidence={ECO:0000269|PubMed:25425668}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76096; CC Evidence={ECO:0000269|PubMed:25425668}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane CC protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=B9DFU2-1; Sequence=Displayed; CC Name=2; CC IsoId=B9DFU2-2; Sequence=VSP_046323; CC -!- TISSUE SPECIFICITY: Expressed in the vascular cylinder (including the CC pericycle) in roots, the cambial region of vascular bundles in CC inflorescence stems and the vascular junctions of axillary regions in CC leaves and flowers. {ECO:0000269|PubMed:15737939}. CC -!- DISRUPTION PHENOTYPE: Increased shoot branching (PubMed:15737939, CC PubMed:16387852, PubMed:20667910, PubMed:21119045, PubMed:23204501). CC Accumulation of 3-hydroxycarlactone (3-HO-CL), 4-hydroxycarlactone (4- CC HO-CL) and 16-hydroxycarlactone (16-HO-CL) but not of their expected CC corresponding metabolites hydroxycarlactonoate (HO-CLAs) CC (PubMed:32399509). {ECO:0000269|PubMed:15737939, CC ECO:0000269|PubMed:16387852, ECO:0000269|PubMed:20667910, CC ECO:0000269|PubMed:21119045, ECO:0000269|PubMed:23204501, CC ECO:0000269|PubMed:32399509}. CC -!- MISCELLANEOUS: The branching phenotypes of the max1, ccd7/max3 and CC ccd8/max4 mutants can be rescued by exogenous treatment with the CC synthetic strigolactone analogs GR24 and 4BD (Probable). However, the CC max1 mutant does not respond to carlactone (CL) (Probable). CC {ECO:0000305|PubMed:23204501, ECO:0000305|PubMed:27194725}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAL91286.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AC004484; AAC14532.2; -; Genomic_DNA. DR EMBL; AC004747; AAM15001.1; -; Genomic_DNA. DR EMBL; CP002685; AEC07803.1; -; Genomic_DNA. DR EMBL; CP002685; AEC07804.1; -; Genomic_DNA. DR EMBL; OZ408684; CAO7036392.1; -; Genomic_DNA. DR EMBL; AY054283; AAL06942.1; -; mRNA. DR EMBL; AY090384; AAL91286.1; ALT_FRAME; mRNA. DR EMBL; AK316903; BAH19609.1; -; mRNA. DR PIR; T02607; T02607. DR RefSeq; NP_565617.2; NM_128175.3. [B9DFU2-1] DR RefSeq; NP_850074.1; NM_179743.2. [B9DFU2-2] DR AlphaFoldDB; B9DFU2; -. DR SMR; B9DFU2; -. DR BioGRID; 2509; 1. DR FunCoup; B9DFU2; 476. DR STRING; 3702.B9DFU2; -. DR GlyGen; B9DFU2; 1 site. DR iPTMnet; B9DFU2; -. DR PaxDb; 3702-B9DFU2; -. DR ProteomicsDB; 238685; -. [B9DFU2-1] DR GeneID; 817157; -. DR KEGG; ath:AT2G26170; -. DR Araport; AT2G26170; -. DR TAIR; AT2G26170; CYP711A1. DR eggNOG; KOG0158; Eukaryota. DR InParanoid; B9DFU2; -. DR OMA; WKRHGVK; -. DR PhylomeDB; B9DFU2; -. DR PRO; PR:B9DFU2; -. DR Proteomes; UP000006548; Chromosome 2. DR ExpressionAtlas; B9DFU2; baseline and differential. DR GO; GO:0009507; C:chloroplast; ISM:TAIR. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; IDA:TAIR. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0004497; F:monooxygenase activity; IEA:InterPro. DR GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro. DR GO; GO:0009926; P:auxin polar transport; IMP:TAIR. DR GO; GO:0016117; P:carotenoid biosynthetic process; TAS:TAIR. DR GO; GO:0009963; P:positive regulation of flavonoid biosynthetic process; IEP:TAIR. DR GO; GO:0009934; P:regulation of meristem structural organization; IMP:TAIR. DR GO; GO:0010223; P:secondary shoot formation; IMP:TAIR. DR FunFam; 1.10.630.10:FF:000152; Cytochrome P450 711A1; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24301; THROMBOXANE-A SYNTHASE; 1. DR PANTHER; PTHR24301:SF2; THROMBOXANE-A SYNTHASE; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 1: Evidence at protein level; KW Alternative splicing; Heme; Iron; Membrane; Metal-binding; Monooxygenase; KW Oxidoreductase; Reference proteome; Transmembrane; Transmembrane helix. FT CHAIN 1..522 FT /note="Cytochrome P450 711A1" FT /id="PRO_0000422062" FT TRANSMEM 14..34 FT /note="Helical" FT /evidence="ECO:0000255" FT BINDING 467 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250|UniProtKB:P04798" FT VAR_SEQ 1..83 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14593172" FT /id="VSP_046323" SQ SEQUENCE 522 AA; 59425 MW; 77E46CD65838398F CRC64; MKTQHQWWEV LDPFLTQHEA LIAFLTFAAV VIVIYLYRPS WSVCNVPGPT AMPLVGHLPL MAKYGPDVFS VLAKQYGPIF RFQMGRQPLI IIAEAELCRE VGIKKFKDLP NRSIPSPISA SPLHKKGLFF TRDKRWSKMR NTILSLYQPS HLTSLIPTMH SFITSATHNL DSKPRDIVFS NLFLKLTTDI IGQAAFGVDF GLSGKKPIKD VEVTDFINQH VYSTTQLKMD LSGSLSIILG LLIPILQEPF RQVLKRIPGT MDWRVEKTNA RLSGQLNEIV SKRAKEAETD SKDFLSLILK ARESDPFAKN IFTSDYISAV TYEHLLAGSA TTAFTLSSVL YLVSGHLDVE KRLLQEIDGF GNRDLIPTAH DLQHKFPYLD QVIKEAMRFY MVSPLVARET AKEVEIGGYL LPKGTWVWLA LGVLAKDPKN FPEPEKFKPE RFDPNGEEEK HRHPYAFIPF GIGPRACVGQ RFALQEIKLT LLHLYRNYIF RHSLEMEIPL QLDYGIILSF KNGVKLRTIK RF //